Khalid E. Ibrahim
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis
Papers in
- Immunology 31
- Psoriasis: Treatment and Pathogenesis 9
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 6
- Co-authors
- Ahmed Nadeem (36 shared papers)Sheikh F. Ahmad (35 shared papers)Naif O. Al‐Harbi (28 shared papers)Sabry M. Attia (25 shared papers)Haseeb A. Khan (12 shared papers)Saleh A. Bakheet (17 shared papers)Ahmed M. El‐Sherbeeny (6 shared papers)Amel O. Bakhiet (3 shared papers)
- Journals
- International Immunopharmacology (15 papers)Saudi Journal of Biological Sciences (7 papers)European Journal of Pharmacology (2 papers)Molecules (2 papers)Experimental and Toxicologic Pathology (2 papers)
- Partner nations
- Saudi ArabiaEgyptIndia
In The Last Decade
Khalid E. Ibrahim
80 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 134
- Biological Psychiatry 96
- Immunology 533
- Pharmacology 132
- Behavioral Neuroscience 53
- Dermatology 130
Countries citing papers authored by Khalid E. Ibrahim
This map shows the geographic impact of Khalid E. Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid E. Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid E. Ibrahim more than expected).
Fields of papers citing papers by Khalid E. Ibrahim
This network shows the impact of papers produced by Khalid E. Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid E. Ibrahim. The network helps show where Khalid E. Ibrahim may publish in the future.
Co-authors
The 25 scholars most cited alongside Khalid E. Ibrahim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 146 | |
| 2 | 2017 | 119 | |
| 3 | 2019 | 78 | |
| 4 | 2019 | 78 | |
| 5 | 2018 | 71 | |
| 6 | 2020 | 68 | |
| 7 | 2020 | 56 | |
| 8 | 2020 | 53 | |
| 9 | 2018 | 53 | |
| 10 | 2017 | 48 | |
| 11 | 2020 | 41 | |
| 12 | 2020 | 40 | |
| 13 | 2017 | 40 | |
| 14 | 2020 | 36 | |
| 15 | 2016 | 36 | |
| 16 | 2015 | 34 | |
| 17 | 2020 | 34 | |
| 18 | 2020 | 31 | |
| 19 | 2020 | 29 | |
| 20 | 2019 | 28 |
About Khalid E. Ibrahim
Khalid E. Ibrahim is a scholar working on Immunology, Molecular Biology, Materials Chemistry, Plant Science and Physiology, having authored 86 papers that have together received 1.8k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (9 papers), Cytokine Signaling Pathways and Interactions (6 papers), Asthma and respiratory diseases (6 papers), Nanoparticles: synthesis and applications (6 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers), Drug-Induced Hepatotoxicity and Protection (6 papers), Dermatology and Skin Diseases (5 papers) and Nanoparticle-Based Drug Delivery (5 papers). The work is most often cited by research in Biological Psychiatry (96 citations), Immunology (533 citations), Pharmacology (132 citations), Behavioral Neuroscience (53 citations) and Dermatology (130 citations). Khalid E. Ibrahim has collaborated with scholars based in Saudi Arabia, Egypt and India. Frequent co-authors include Ahmed Nadeem, Sheikh F. Ahmad, Naif O. Al‐Harbi, Sabry M. Attia, Haseeb A. Khan, Saleh A. Bakheet, Ahmed M. El‐Sherbeeny, Amel O. Bakhiet, Mohsen G. Al‐Mutary and Faleh Alqahtani. Their work appears in journals such as International Immunopharmacology, Saudi Journal of Biological Sciences, European Journal of Pharmacology, Molecules and Experimental and Toxicologic Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.